Generation and transplantation of an autologous vascularized bioartificial human tissue

Transplantation

Volumn 88, Issue 2, 2009, Pages 203-210

  Mertsching, Heike ^a   Schanz, Johanna ^a   Steger, Volker ^b   Schandar, Markus ^a   Schenk, Martin ^c   Hansmann, Jan ^a   Dally, Iris ^a   Friedel, Godehard ^b   Walles, Thorsten ^a,b,d  

^a FRAUNHOFER INSTITUTE FOR INTERFACIAL ENGINEERING AND BIOTECHNOLOGY IGB   (Germany)

^b Schillerhöhe Specialist Hospital   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d Schillerhoehe Hospital   (Germany)

Author keywords

Clinical transplantation; Tissue engineering; Vascularization

Indexed keywords

ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; BIOARTIFICIAL ORGAN; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; TISSUE ENGINEERING; TISSUE PREPARATION; TISSUE TRANSPLANTATION; VASCULARIZATION;

ANIMALS; BIOARTIFICIAL ORGANS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; JEJUNUM; RATS; SWINE; TISSUE ENGINEERING; TRANSPLANTATION, AUTOLOGOUS;

EID: 68249114783     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ac15e1     Document Type: Article

References (31)

1. Kwan MD, Longaker MT. Regenerative medicine: The next frontier. Transplantation 2008; 86: 206.
2. Birchall M, Macchiarini P. Airway transplantation: A debate worth having? Transplantation 2008; 85: 1075.
3. Vacanti JP, Langer R. Tissue engineering: The design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 1999; 354(suppl 1): SI32.
4. Sefton MV, Babensee JE, Woodhouse KA. Innate and adptive immune responses in tissue engineering. Semin Immunol 2008; 20: 83.
5. Jain RK, Au P, Tam J, et al. Engineering vascularized tissue. Nat Biotechnol 2005; 23: 821.
6. Mertsching H, Walles T, Hofmann M, et al. Engineering of a vascularized scaffold for artificial tissue and organ generation. Biomaterials 2005; 26: 6610.
7. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989; 119: 203.
8. Thom SM, Horobin RW, Seidler E, et al. Factors affecting the selection and use of tetrazolium salts as cytochemical indicators of microbial viability and activity. J Appl Bacteriol 1993; 74: 433.
9. Loebe M, Alexi-Meskhishvili V, Wenig Y, et al. Use of polytetrafluoroethylene surgical membrane as a pericardial substitute in the correction of congenital heart defects. Tex Heart Inst J 1993; 20: 213.
10. Fuchs JR, Nasseri BA, Vacanti JP. Tissue engineering: A 21st century solution to surgical reconstruction. Ann Thorac Surg 2001; 72: 577.
11. Atala A. Tissue engineering and regenerative medicine: Concepts for clinical application. Rejuvenation Res 2004; 7: 15.
12. Walles T, Mertsching H. Strategies for scaffold vascularization in tissue engineering. In: Kendall JB, ed. Biomaterials research advances. New York, Nova Science Publishers 2007, pp 183.
13. Levenberg S, Langer R. Advances in tissue engineering. Curr Top Dev Biol 2004; 61: 113.
14. Walles T, Herden T, Haverich A, et al. Influence of scaffold thickness and scaffold composition on bioartificial graft survival. Biomaterials 2003; 24: 1233.
15. Badylak SF, Gilbert TW. Immune response to biologic scaffold materials. Semin Immunol 2008; 20: 109.
16. Schanz JE. Aufbau eines vaskuluarisierten Lebertestsystems [Generation of a vascularized liver test system]. Saarbrücken, VDM 2008; ISBN 3639065824.
17. Macchiarini P, Walles T, Biancosino C, et al. First human transplantation of a bioengineered airway tissue. J Thorac Cardiovasc Surg 2004; 128: 638.
18. Walles T, Biancosino C, Zardo P, et al. Tissue remodelling in a bioartificial fibromuscular patch following transplantation in a human. Transplantation 2005; 80: 284.
19. Schultheiss D, Gabouev AI, Cebotari S, et al. Biological vascularized matrix for bladder tissue engineering: Matrix preparation, reseeding technique and short-term implantation in a porcine model. J Urol 2005; 173: 276.
20. Walles T, Steger V, Wurst H, et al. Pumpless extracorporeal gas exchange aiding central airway surgery. J Thorac Cardiovasc Surg 2008; 136: 1372.
21. Stone KR, Abdel-Motal UM, Walgenbach AW, et al. Replacement of human anterior cruciate ligaments with pig ligaments: A model for anti-non-gal antibody response in long-term xenotransplantation. Transplantation 2007; 83: 211.
22. McPherson TB, Liang H, Record RD, et al. Galalpha(1,3)Gal epitope in porcine small intestinal submucosa. Tissue Eng 2000; 6: 233.
23. Konakci KZ, Bohle B, Blumer R, et al. Alpha-Gal on bioprostheses: Xenograft immune response in cardiac surgery. Eur J Clin Invest 2005; 35: 17.
24. Reider E, Seebacher G, Kasimir MT, et al. Tissue engineering of heart valves. Decellularized porcine and human valve scaffolds differ importantly in residual potential to attract moncytic cells. Circulation 2005; 111: 2792.
25. Raeder RH, Badylak SF, Sheehan C, et al. Natural anti-galactose alpha 1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts. Transpl Immunol 2002; 10: 15.
26. Walles T, Puschmann C, Haverich A, et al. Acellular implantation - No alternative to tissue engineering. Int J Artif Org 2003; 26: 225.
27. Methe H, Hess S, Edelman ER. The effect of three-dimensional matrix-embedding of endothelial cells on the humoral and cellular immune response. Semin Immunol 2008; 20: 117.
28. Eiselt P, Kim BS, Chacko B, et al. Development of technologies aiding large-tissue engineering. Biotechnol Prog 1998; 14: 134.
29. Anderson JM. Biological responses to materials. Ann Rev Mater Res 2001; 31: 81.
30. Luttikhuizen DT, Harmsen MC, Van Luyn MJ. Cellular and molecular dynamics in the foreign body reaction. Tissue Eng 2006; 12: 1955.
31. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol 2008; 20: 86.